Delivery Order SPE2DR25D2203-SPE2DR26FD2WS
Award Date 1/29/26
Potential Completion Date 1/30/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On January 7, 2026, the Defense Logistics Agency awarded a $40,985.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This non-set-aside contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- On January 16, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,426.63 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which carries an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this award, with its parent company being Cencora, Inc....
- On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,117.24 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The contract carries no set-aside designation and represents a small-value transaction within...
- The Defense Logistics Agency awarded a $14,128.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on January 22, 2026, with completion scheduled for January 23, 2026. This non-set-aside delivery order was placed against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $11,808.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 10, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. REPATHA is a prescription medication used to treat high cholesterol, and...
- On January 27, 2026, the Defense Logistics Agency awarded a delivery order valued at $22,330.20 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which has no set-aside designation, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the contractor's location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $180,656.51 by the Defense Logistics Agency on January 28, 2026, for the supply of REPATHA 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which carries an ultimate completion date of January 29, 2026, represents a non-set-aside, competitively awarded contract. The award was issued under AmerisourceBergen's parent organization,...
- The Defense Logistics Agency awarded a delivery order valued at $81,340.66 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- On January 20, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $28,431.20 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 21, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement...